OpenAlex

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia

BMJ Open Gastroenterology 5(1) (2018)

Bin Wei; Fanpu Ji; Yee Hui Yeo; Eiichi Ogawa; Christopher Donald Stave; Shuangsuo Dang; Zongfang Li; Norihiro Furusyo; Ramsey C Cheung; Mindie H. Nguyen

Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin)

Journal of Medical Virology 92(12) (2020)

Braira Wahid; Khadija Shami; Salman A. Joiya; Sevilay Ece GÜMÜŞ ÖZUYAR; Muhammad Idrees

Sofosbuvir and Ribavirin Combination Therapy Response in Various Hepatitis C Virus Genotypes in Peshawar, Khyber Pakhtunkhwa

Jundishapur Journal of Microbiology 13(6) (2020)

Saima Ali Haider; Bashir Ahmad; Sajid Ali; Ali Haider; Shumaila Bashir; Nourin Mahmood

Prediction of response to sofosbuvir-based therapy using serum interleukin-12 and single nucleotide polymorphism of the interleukin 28B gene as predictive factors in HCV positive genotype-4 patients

Medicine 102(28) (2023)

Doaa Mohamed Abdelnajid; Ahmed Yahia Elmowafy; Lionel P. E. Rostaing; Marwa Tarek ElRakaiby

Ribavirin

Reactions Weekly 1669(1) (2017)

Studying the Kynurenine, Some Hematological and Biochemical Changes on Egyptian Patients with Chronic Hepatitis C During and After Treatment with Sofosbuvir

Benha Journal of Applied Sciences 5(7) (2020)

N. H. Abdel Hameid; L.Y. Mousa; Eman Shaheen; F. S. Ibrahim